// App-Quantinova.ai

363 : Dantrolene Decreases Susceptibility to Refibrillations by Restoring Vf Dependent Cardiac Calcium Handling Dysfunction

Researchers

Presenter

  • Marjan Kusha

Principal Investigators

  • Stephane Masse

  • Mohammad Ali Azam

  • Patrick Lai

  • Chris Meyer

Medical Centers

  • Toronto Western Hospital, Toronto, ON, Canada

  • Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Arrhythmia

  • The ataxia neuropathy spectrum

Biomarkers

  • Ryanodine receptor type 2

Drug/Treatment

  • Dantrolene Injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved